Literature DB >> 6216579

Autologous mixed lymphocyte reactions in patients with rheumatoid arthritis and juvenile rheumatoid arthritis: both non-T cells and in-vivo-activated T cells can act as stimulator cells.

O Førre, T Egeland, J H Dobloug, T K Kvien, J B Natvig.   

Abstract

The lymphocyte responses in autologous mixed lymphocyte reactions (AMLR) between irradiated non-T and T lymphocytes from the peripheral blood (PB) of rheumatoid arthritis (RA) and juvenile RA (JRA) patients were decreased compared with the AMLR responses of normal PB lymphocytes. Normal AMLR responses were seen in synovial tissue and the synovial fluid lymphocytes from RA and JRA patients. The lymphocyte responses were also decreased in AMLR between irradiated non-T cells from peripheral blood and T cells from synovial tissue (ST) in RA patients and between irradiated non-T from PB and synovial fluid (SF) T cells in JRA patients. However, when irradiated non-T cells from ST of RA patients or from SF of JRA patients were mixed with autologous PB T lymphocytes, increased lymphocyte responses were observed. SF T lymphocytes and ST T cells were also shown to stimulate autologous PB T lymphocytes.

Entities:  

Mesh:

Year:  1982        PMID: 6216579     DOI: 10.1111/j.1365-3083.1982.tb00712.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  10 in total

1.  Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  G Lemm; H Warnatz
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

2.  Activation of OKT4 suppressor cells in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.

Authors:  K Oen; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

Review 3.  Antigen presenting cells in situ: their identification and involvement in immunopathology.

Authors:  L W Poulter
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

4.  T cell interactions in active rheumatoid arthritis: insights from the human autologous mixed lymphocyte reaction as a model of T cell activation cascade.

Authors:  T Sakane; Y Murakawa; M Takeno; T Shigeki; H Nagafuchi; T Miki
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 5.  Autoantibody profile in juvenile chronic arthritis.

Authors:  A M Leak
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

6.  Correlation of disease activity and drug therapy with the autologous mixed lymphocyte reaction in rheumatoid arthritis.

Authors:  S M Cross; R A Hazelton
Journal:  Ann Rheum Dis       Date:  1985-04       Impact factor: 19.103

Review 7.  Mechanisms of autoimmunity in type I diabetes.

Authors:  D Faustman
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

8.  Analysis of the responding and stimulating cells in the AMLR of patients with rheumatoid arthritis using limiting dilution.

Authors:  R A Hazelton; J J Morrison; R Vedam; V Siskind
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

9.  Increment of CD8S6F1 cells in synovial fluid from patients with rheumatoid arthritis.

Authors:  Y Ueki; K Eguchi; S Miyake; S Nagataki; Y Tominaga
Journal:  Ann Rheum Dis       Date:  1994-12       Impact factor: 19.103

10.  Second-line drug treatment in rheumatoid arthritis associated with depressed autologous mixed lymphocyte reaction.

Authors:  G S Panayi; M M Mills
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.